UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2020-01, Vol.31 (1), p.17-29

2020

Volltextzugriff (PDF)

The aetiology of B‐cell lymphoid malignancies with a focus on chronic inflammation and infections

Journal of internal medicine, 2017-11, Vol.282 (5), p.360-370

2017

Volltextzugriff (PDF)

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

Leukemia, 2015-01, Vol.29 (1), p.66-75

2015

Volltextzugriff (PDF)

Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients

Leukemia, 2007-02, Vol.21 (2), p.340-350

2007

Volltextzugriff (PDF)

Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma

Annals of oncology, 2014-02, Vol.25 (2), p.316-322

2014

Volltextzugriff (PDF)

Evidence for an association between Chlamydia psittaci and Ocular adnexal lymphomas

JNCI : Journal of the National Cancer Institute, 2004-04, Vol.96 (8), p.586-594

2004

Volltextzugriff (PDF)

A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects

Journal of controlled release, 2016-02, Vol.223, p.165-177

2016

Volltextzugriff (PDF)

The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation

Leukemia, 2020-01, Vol.34 (1), p.257-270

2020

Volltextzugriff (PDF)

Corrigendum to “Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 31 (2020) 17–29]

Annals of oncology, 2023-03, Vol.34 (3), p.325-325

2023

Volltextzugriff (PDF)

Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2024-06, Vol.35 (6), p.491-507

2024

Volltextzugriff (PDF)

Lymphadenitis/Reactive-Hyperplasia, Mimickers of Lymphomas, Low-Grade B-Cell Lymphomas, and Hodgkin Lymphoma

Hemato, 2024-09, Vol.5 (3), p.350-379

2024

Volltextzugriff (PDF)

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

Leukemia, 2018-02, Vol.32 (2), p.353-363

2018

Volltextzugriff (PDF)

EAHP 2020 workshop proceedings, pediatric myeloid neoplasms

Virchows Archiv : an international journal of pathology, 2022-10, Vol.481 (4), p.621-646

2022

Volltextzugriff (PDF)

Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium

Leukemia, 2016-02, Vol.30 (2), p.361-372

2016

Volltextzugriff (PDF)

Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma

Leukemia, 2017-04, Vol.31 (4), p.967-970

2017

Volltextzugriff (PDF)

Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications

Leukemia, 2012-07, Vol.26 (7), p.1638-1646

2012

Volltextzugriff (PDF)

Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas

Annals of oncology, 2016-06, Vol.27 (6), p.1123-1128

2016

Volltextzugriff (PDF)

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VKMYC model of multiple myeloma

Haematologica (Roma), 2015-06, Vol.100 (6), p.834-841

2015

Volltextzugriff (PDF)

A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.)

Virchows Archiv : an international journal of pathology, 2019-10, Vol.475 (4), p.513-518

2019

Volltextzugriff (PDF)

A multicenter study of treatment of primary CNS lymphoma

Neurology, 2002-05, Vol.58 (10), p.1513-1520

2002

Volltextzugriff (PDF)

Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma

The Journal of pathology, 2008-11, Vol.216 (3), p.356-364

2008

Volltextzugriff (PDF)

THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTACI ERADICATION WITH A SIX‐MONTH REGIMEN OF DOXYCYCLINE IN PATIENTS WITH STAGE‐I MALT LYMPHOMA OF THE OCULAR ADNEXAE

Hematological oncology, 2023-06, Vol.41 (S2), p.106-107

2023

Volltextzugriff (PDF)

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib

Journal of controlled release, 2014-10, Vol.192, p.157-166

2014

Volltextzugriff (PDF)

MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM FOR MYELODYSPLASTIC SYNDROMES: A MONOCENTRIC EXPERIENCE

Leukemia research reports, 2024, Vol.21, p.100431, Article 100431

2024

Volltextzugriff (PDF)

1 – 25 von 749

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(670)
Mit Volltextzugriff
(659)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(454)
Life Sciences & Biomedicine
(370)
Humans
(330)
Biological And Medical Sciences
(165)
Female
(160)
Male
(157)
Oncology
(157)
Medical Sciences
(132)
Middle Aged
(121)
Adult
(110)
Aged
(105)
Hematology
(104)
Animals
(83)
Lymphoma
(76)
Technology
(73)
Prognosis
(68)
Hematologic And Hematopoietic Diseases
(66)
Aged, 80 And Over
(63)
Tumors
(59)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(58)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(363)
Free E-Journal (出版社公開部分のみ）
(362)
Ingenta
(279)
Lippincott Journal Package
(263)
Elsevier ScienceDirect Journals Complete
(185)
Publisher or Other Site
(156)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(130)
Wiley-Blackwell Journals
(119)
Wiley Online Library
(102)
IngentaConnect Journals
(91)
Nature Journals
(58)
Springer Journals
(39)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(35)
Nexis Uni
(33)
SpringerLink Series
(23)
Oxford Journals
(21)
Taylor & Francis Online
(20)
Taylor & Francis
(19)
Oxford Journals 2020 Medicine
(17)
IEEE Xplore
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The aetiology of B‐cell lymphoid malignancies with a focus on chronic inflammation and infections

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients

Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma

Evidence for an association between Chlamydia psittaci and Ocular adnexal lymphomas

A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects

The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation

Corrigendum to “Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 31 (2020) 17–29]

Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Lymphadenitis/Reactive-Hyperplasia, Mimickers of Lymphomas, Low-Grade B-Cell Lymphomas, and Hodgkin Lymphoma

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

EAHP 2020 workshop proceedings, pediatric myeloid neoplasms

Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium

Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma

Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications

Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VKMYC model of multiple myeloma

A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.)

A multicenter study of treatment of primary CNS lymphoma

Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma

THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTACI ERADICATION WITH A SIX‐MONTH REGIMEN OF DOXYCYCLINE IN PATIENTS WITH STAGE‐I MALT LYMPHOMA OF THE OCULAR ADNEXAE

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib

An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-204 Receptors

MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM FOR MYELODYSPLASTIC SYNDROMES: A MONOCENTRIC EXPERIENCE

Suchergebnisse filtern